← Leaderboards
Alec J Hirsch
Oregon Health & Science University
$3,522,343
Attributed
$3,734,093
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $763.7K · FY2012–24$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,734,093 · 3
By mechanism
R01$2,833,703 · 1
R21$900,390 · 2
Top collaborators
- Jacob Raber2 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jay Nelson$21,289,993
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposVirus DiseasesFlavivirusInfectionVirusMouse ModelBrainCytokineProductionResponseReportingCohortDoseViralPositioning AttributeEvaluationProteinsDisease OutbreaksDesignCultured CellsAdjuvantC Type Lectin ReceptorsEventCell Culture Techniques
Grant awards (10)
Development of a Virus-Like Particle Vaccine for Powassan Virus$478,362
R01 · FY2024 · AI · contact PI
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology$192,500
R21 · FY2024 · AG
Development of a Virus-Like Particle Vaccine for Powassan Virus$532,748
R01 · FY2023 · AI · contact PI
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology$231,000
R21 · FY2023 · AG
Development of a Virus-Like Particle Vaccine for Powassan Virus$522,996
R01 · FY2022 · AI · contact PI
Development of a Virus-Like Particle Vaccine for Powassan Virus$231,000
R01 · FY2022 · AI · contact PI
Development of a Virus-Like Particle Vaccine for Powassan Virus$500,433
R01 · FY2021 · AI · contact PI
Development of a Virus-Like Particle Vaccine for Powassan Virus$568,164
R01 · FY2020 · AI · contact PI
Evaluation of Host miRNAs as Therapeutics against Encephalitogenic Flaviviruses$211,481
R21 · FY2013 · AI · contact PI
Evaluation of Host miRNAs as Therapeutics against Encephalitogenic Flaviviruses$265,409
R21 · FY2012 · AI · contact PI